Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8158)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2021 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shengir M, Elgara M, Sebastiani G. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World J Gastroenterol 2021; 27(17): 1959-1972 [PMID: 34007133 DOI: 10.3748/wjg.v27.i17.1959] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2824/full/v27/i17/1959.htm |
| Number | Citing Articles |
| 1 |
Michał Brzdęk, Dorota Zarębska-Michaluk, Piotr Rzymski, Beata Lorenc, Justyna Janocha-Litwin, Hanna Berak, Krzysztof Tomasiewicz, Marek Sitko, Włodzimierz Mazur, Ewa Janczewska, Dorota Dybowska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Jerzy Jaroszewicz, Anna Piekarska, Robert Flisiak. Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-06290-5
|
| 2 |
Evgeniy V. Kryukov, Dmitry V. Cherkashin, Vladimir V. Saluhov, Konstantin V. Matjushenko, Aleksey D. Sobolev, Nikolaj N. Shcherbina. Extrahepatic manifestations of chronic viral hepatitis C. Bulletin of the Russian Military Medical Academy 2022; 24(2): 341 doi: 10.17816/brmma103982
|
| 3 |
Suguru Kurokawa, Masato Yoneda, Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Kento Imajo, Satoru Saito, Atsushi Nakajima, Kikuko Hotta. Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02360-4
|
| 4 |
Malini M. Gandhi, Kim-Lien Nguyen, Jordan E. Lake, Diana Liao, Aleen Khodabakhshian, Mario Guerrero, Chrisandra L. Shufelt, C. Noel Bairey Merz, Wilbert C. Jordan, Eric S. Daar, Debika Bhattacharya, Kara W. Chew. Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation. AIDS 2024; 38(3): 317 doi: 10.1097/QAD.0000000000003739
|
| 5 |
Anaïs Corma-Gómez, Diana Corona-Mata, Jésica Martín-Carmona, María José Galindo, Angela Camacho, Carmen Martín-Sierra, Marina Gallo-Marín, Pilar Rincón, Ignacio Perez-Valero, Margarita Pérez-García, Angela Carrasco-Dorado, Juan A Pineda, Antonio Rivero-Juárez, Antonio Rivero, Luis M Real, Juan Macías. FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure. Open Forum Infectious Diseases 2025; 12(4) doi: 10.1093/ofid/ofae628
|
| 6 |
Zuzana Macek Jilkova, Komal Saleem, Samia Afzal, Thomas Decaens. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV. Livers 2021; 1(4): 313 doi: 10.3390/livers1040024
|
| 7 |
Michele A. La Merrill, Martyn T. Smith, Cliona M. McHale, Jerrold J. Heindel, Ella Atlas, Matthew C. Cave, David Collier, Kathryn Z. Guyton, Suneil Koliwad, Angel Nadal, Christopher J. Rhodes, Robert M. Sargis, Lauren Zeise, Bruce Blumberg. Consensus on the key characteristics of metabolism disruptors. Nature Reviews Endocrinology 2025; 21(4): 245 doi: 10.1038/s41574-024-01059-8
|
| 8 |
Wesal Elgretli, Tianyan Chen, Nadine Kronfli, Giada Sebastiani. Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines 2023; 11(2): 271 doi: 10.3390/biomedicines11020271
|
| 9 |
Yu‐Ping Chang, Ji‐Yuh Lee, Chi‐Yi Chen, Wei‐Yu Kao, Chih‐Lin Lin, Sheng‐Shun Yang, Yu‐Lueng Shih, Cheng‐Yuan Peng, Fu‐Jen Lee, Ming‐Chang Tsai, Shang‐Chin Huang, Tung‐Hung Su, Tai‐Chung Tseng, Chun‐Jen Liu, Pei‐Jer Chen, Jia‐Horng Kao, Chen‐Hua Liu. Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection. Alimentary Pharmacology & Therapeutics 2025; 61(9): 1508 doi: 10.1111/apt.70029
|
| 10 |
Jesus Torres-Flores, Nora A. Fierro. Are previous viral infections important for the COVID-19 outcomes?. Annals of Hepatology 2021; 25: 100554 doi: 10.1016/j.aohep.2021.100554
|